MCRB
Seres Therapeutics, Inc.
Company overview
- Market capitalization
- $34.99M
- Employees
- 66
- Latest publication
- 2026-09-29
About Seres Therapeutics, Inc.
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q3 20242024-09-30 · USD | Q2 20232023-06-30 · USD | Q1 20232023-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 736,000USD | 358,000USD | 438,000USD | 0USD | 0USD | 0USD | 126,473,000USD | -522,000USD |
| Research Development | 9,141,000USD | 13,195,000USD | 11,684,000USD | 12,939,000USD | 11,821,000USD | 16,460,000USD | 46,792,000USD | 43,969,000USD |
| General And Administrative Expenses | 7,061,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 22,009,000USD | 20,484,000USD | 33,620,000USD | 23,822,000USD | 23,709,000USD | 27,766,000USD | 30,157,000USD | 26,077,000USD |
| Operating Income | -21,273,000USD | -20,907,000USD | -19,377,000USD | -24,881,000USD | -27,236,000USD | -29,170,000USD | 49,524,000USD | -70,568,000USD |
| Total Other Income Expense Net | 25,854,000USD | 994,000USD | 4,042,000USD | 5,026,000USD | 59,918,000USD | -21,865,000USD | -2,972,000USD | -606,000USD |
| Interest Income | 181,000USD | 325,000USD | 445,000USD | 546,000USD | 618,000USD | 652,000USD | 1,726,000USD | 1,032,000USD |
| Net Income | 4,581,000USD | -19,913,000USD | -15,335,000USD | -19,855,000USD | 32,682,000USD | 88,776,000USD | 46,552,000USD | -71,174,000USD |
| Cost Of Revenue | — | 781,000USD | -13,805,000USD | 1,059,000USD | 3,527,000USD | 1,404,000USD | 46,792,000USD | 43,969,000USD |
| Gross Profit | — | -423,000USD | 14,243,000USD | -1,059,000USD | -3,527,000USD | -1,404,000USD | 79,681,000USD | -44,491,000USD |
| Selling General Administrative | — | 8,070,000USD | 7,539,000USD | 10,253,000USD | 11,888,000USD | 12,710,000USD | 28,051,000USD | 22,470,000USD |
| Net Interest Income | — | 325,000USD | 445,000USD | 546,000USD | 618,000USD | 652,000USD | -1,461,000USD | -916,000USD |
| Income Before Tax | — | -19,913,000USD | -15,335,000USD | -19,855,000USD | 32,682,000USD | -51,035,000USD | 46,552,000USD | -71,174,000USD |
| Net Income From Continuing Ops | — | -19,913,000USD | -15,335,000USD | -19,855,000USD | 32,682,000USD | -51,035,000USD | 46,552,000USD | -71,174,000USD |
| Ebit | — | -19,913,000USD | -15,335,000USD | -19,855,000USD | 32,682,000USD | -51,035,000USD | 49,739,000USD | -69,226,000USD |
| Ebitda | — | -19,132,000USD | -13,200,000USD | -18,796,000USD | 33,758,000USD | -49,631,000USD | 51,266,000USD | -67,826,000USD |
| Depreciation And Amortization | — | 781,000USD | 2,135,000USD | 1,059,000USD | 1,076,000USD | 1,404,000USD | 1,527,000USD | 1,400,000USD |
| Reconciled Depreciation | — | 781,000USD | 954,000USD | 1,059,000USD | 1,076,000USD | 1,404,000USD | 1,527,000USD | 1,400,000USD |
| Unclassified Operating Expenses | — | — | 14,397,000USD | — | — | -1,404,000USD | -44,686,000USD | -40,362,000USD |
| Interest Expense | — | — | — | 0USD | 0USD | 0USD | 3,187,000USD | 1,948,000USD |
| Income Tax Expense | — | — | — | — | — | — | 149,000USD | 606,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | 46,552,000USD | -71,174,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 1,342,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20152015-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|
| Total Revenue | 0USD | — | — |
| Cost Of Revenue | 728,000USD | — | — |
| Gross Profit | -728,000USD | — | — |
| Research Development | 38,095,000USD | 4,805,000USD | 2,077,000USD |
| Selling General Administrative | 16,761,000USD | 1,247,000USD | 956,000USD |
| Total Operating Expenses | 54,856,000USD | 6,052,000USD | 3,033,000USD |
| Operating Income | -54,856,000USD | -6,052,000USD | -3,033,000USD |
| Interest Income | 631,000USD | — | — |
| Interest Expense | 555,000USD | 42,000USD | 0USD |
| Income Before Tax | -54,780,000USD | -6,102,000USD | -3,126,000USD |
| Income Tax Expense | -804,000USD | 42,000USD | — |
| Net Income | -54,780,000USD | -6,102,000USD | -3,126,000USD |
| Net Income From Continuing Ops | -54,780,000USD | — | — |
| Ebit | -54,856,000USD | -6,052,000USD | -3,033,000USD |
| Ebitda | -54,128,000USD | -5,964,000USD | -3,008,000USD |
| Depreciation And Amortization | 728,000USD | 88,000USD | 25,000USD |
| Total Other Income Expense Net | 76,000USD | -50,000USD | -93,000USD |
| Non Operating Income Net Other | 631,000USD | — | — |
| Net Income Applicable To Common Shares | -54,780,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 101,588,000USD | 117,618,000USD | 138,193,000USD | 143,473,000USD | 143,800,000USD | 164,182,000USD | 139,810,000USD | 178,742,000USD |
| Cash And Equivalents | 15,594,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 42,348,000USD | 31,837,000USD | 49,376,000USD | 51,527,000USD | 48,685,000USD | 66,078,000USD | 38,674,000USD | 72,928,000USD |
| Other Current Assets | 1,480,000USD | 1,770,000USD | 3,250,000USD | 3,112,000USD | 2,424,000USD | 2,846,000USD | 3,130,000USD | 6,104,000USD |
| Other Non Current Assets | 31,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 67,054,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 20,031,000USD | 19,344,000USD | 19,322,000USD | 22,429,000USD | 30,940,000USD | 31,323,000USD | 41,222,000USD | 64,833,000USD |
| Other Non Current Liabilities | 2,207,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 34,534,000USD | 26,499,000USD | 44,218,000USD | 43,697,000USD | 32,950,000USD | 50,465,000USD | 13,784,000USD | 23,919,000USD |
| Total Equity Including Noncontrolling Interest | 34,534,000USD | — | — | — | — | — | — | — |
| Net Receivables | 274,000USD | 233,000USD | 360,000USD | 777,000USD | 882,000USD | 4,383,000USD | 4,751,000USD | — |
| Property Plant Equipment Net | 56,966,000USD | 77,082,000USD | 80,118,000USD | 83,247,000USD | 86,416,000USD | 89,405,000USD | 92,437,000USD | 95,476,000USD |
| Accounts Payable | 1,186,000USD | 2,338,000USD | 1,682,000USD | 1,677,000USD | 2,200,000USD | 2,168,000USD | 4,079,000USD | 8,254,000USD |
| Short Term Debt | 11,828,000USD | 10,865,000USD | 10,390,000USD | 9,920,000USD | 9,478,000USD | 9,049,000USD | 8,674,000USD | 8,346,000USD |
| Common Stock | 10,000USD | 10,000USD | 10,000USD | 9,000USD | 9,000USD | 9,000USD | 173,000USD | 170,000USD |
| Retained Earnings | -987,735,000USD | -992,316,000USD | -972,403,000USD | -957,068,000USD | -965,272,000USD | -945,417,000USD | -978,099,000USD | -962,462,000USD |
| Total Liab | — | 91,119,000USD | 93,975,000USD | 99,776,000USD | 110,850,000USD | 113,717,000USD | 126,026,000USD | 154,823,000USD |
| Other Current Liab | — | 6,141,000USD | 7,250,000USD | 10,832,000USD | 19,262,000USD | 20,106,000USD | 28,469,000USD | 48,233,000USD |
| Capital Stock | — | 10,000USD | 10,000USD | 9,000USD | 9,000USD | 9,000USD | 173,000USD | 170,000USD |
| Other Assets | — | 1USD | — | — | — | — | — | — |
| Cash | — | 29,834,000USD | 45,766,000USD | 47,638,000USD | 45,379,000USD | 58,849,000USD | 30,793,000USD | 66,824,000USD |
| Cash And Short Term Investments | — | 29,834,000USD | 45,766,000USD | 47,638,000USD | 45,379,000USD | 58,849,000USD | 30,793,000USD | 66,824,000USD |
| Net Debt | — | 50,665,000USD | 37,200,000USD | 37,615,000USD | 42,055,000USD | 30,699,000USD | 60,847,000USD | 26,788,000USD |
| Short Long Term Debt Total | — | 80,499,000USD | 82,966,000USD | 85,253,000USD | 87,434,000USD | 89,548,000USD | 91,640,000USD | 93,612,000USD |
| Property Plant Equipment Gross | — | 134,476,000USD | 136,731,000USD | 139,622,000USD | 141,747,000USD | 143,677,000USD | 145,633,000USD | 147,648,000USD |
| Common Stock Shares Outstanding | — | 9,582,533shares | 8,869,742shares | 8,771,519shares | 8,743,733shares | 8,714,701shares | 8,650,409shares | 7,632,411shares |
| Non Current Assets Total | — | 85,780,999USD | 88,817,000USD | 91,946,000USD | 95,115,000USD | 98,104,000USD | 101,136,000USD | 105,814,000USD |
| Non Current Liabilities Total | — | 71,775,000USD | 74,652,999USD | 77,347,000USD | 79,910,000USD | 82,394,000USD | 84,804,000USD | 89,990,000USD |
| Non Current Liabilities Other | — | 2,141,000USD | 2,077,000USD | 2,014,000USD | 1,954,000USD | 1,895,000USD | 1,838,000USD | 1,783,000USD |
| Non Currrent Assets Other | — | 30,999USD | 31,000USD | 31,000USD | 31,000USD | 31,000USD | 31,000USD | 10,338,000USD |
| Net Working Capital | — | 12,493,000USD | 30,054,000USD | 29,098,000USD | 17,745,000USD | 34,755,000USD | -2,548,000USD | 8,095,000USD |
| Unclassified Non Current Assets | — | 8,667,999USD | 8,668,000USD | 8,668,000USD | 8,668,000USD | 8,668,000USD | 8,668,000USD | — |
| Unclassified Non Current Liabilities | — | 69,634,000USD | 72,575,999USD | 75,333,000USD | 77,956,000USD | 80,499,000USD | 82,966,000USD | 88,207,000USD |
| Unclassified Equity | — | 1,018,795,000USD | 1,016,601,000USD | 1,000,747,000USD | 998,204,000USD | 995,864,000USD | 991,537,000USD | 986,041,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 138,193,000USD | 139,810,000USD | 358,600,000USD | 348,784,000USD | 354,859,000USD | 342,940,000USD | 132,440,000USD | 120,472,000USD |
| Other Current Assets | 3,250,000USD | 3,130,000USD | 17,798,000USD | 13,423,000USD | 12,922,000USD | 5,774,000USD | 3,588,000USD | 13,690,000USD |
| Total Liab | 93,975,000USD | 126,026,000USD | 403,456,000USD | 338,001,000USD | 223,352,000USD | 168,190,000USD | 180,764,000USD | 168,517,000USD |
| Total Stockholder Equity | 44,218,000USD | 13,784,000USD | -44,856,000USD | 10,783,000USD | 131,507,000USD | 174,750,000USD | -48,324,000USD | -48,045,000USD |
| Other Current Liab | 7,250,000USD | 28,469,001USD | 81,701,000USD | 59,840,000USD | 45,094,000USD | 14,226,000USD | 10,884,000USD | 15,207,000USD |
| Common Stock | 10,000USD | 173,000USD | 135,000USD | 125,000USD | 92,000USD | 91,000USD | 70,000USD | 41,000USD |
| Capital Stock | 10,000USD | 173,000USD | 135,000USD | 125,000USD | 92,000USD | 91,000USD | 70,000USD | 41,000USD |
| Retained Earnings | -972,403,000USD | -978,099,000USD | -978,235,000USD | -864,511,000USD | -614,354,000USD | -548,776,000USD | -459,649,000USD | -389,370,000USD |
| Cash | 45,766,000USD | 30,793,000USD | 127,965,000USD | 163,030,000USD | 180,002,000USD | 116,049,000USD | 65,126,000USD | 85,820,000USD |
| Cash And Short Term Investments | 45,766,000USD | 30,793,000USD | 127,965,000USD | 181,341,000USD | 290,706,000USD | 253,616,000USD | 94,816,000USD | 85,820,000USD |
| Total Current Assets | 49,376,000USD | 38,674,000USD | 175,410,000USD | 194,764,000USD | 303,628,000USD | 268,777,000USD | 100,189,000USD | 92,665,000USD |
| Total Current Liabilities | 19,322,000USD | 41,222,000USD | 98,659,000USD | 85,596,000USD | 82,258,000USD | 46,415,000USD | 45,993,000USD | 42,041,000USD |
| Net Debt | 37,200,000USD | 60,847,000USD | 70,818,000USD | -440,000USD | -130,791,000USD | -75,280,000USD | -20,346,000USD | -78,570,000USD |
| Short Term Debt | 10,390,000USD | 8,674,000USD | 5,587,000USD | 4,057,000USD | 6,610,000USD | 5,569,000USD | 4,456,000USD | 12,066,000USD |
| Short Long Term Debt Total | 82,966,000USD | 91,640,000USD | 198,783,000USD | 162,590,000USD | 49,211,000USD | 40,769,000USD | 44,780,000USD | 7,250,000USD |
| Net Receivables | 360,000USD | 4,751,000USD | 8,674,000USD | — | 0USD | 9,387,000USD | 1,785,000USD | — |
| Accounts Payable | 1,682,000USD | 4,078,999USD | 3,641,000USD | 17,440,000USD | 13,735,000USD | 4,018,000USD | 4,859,000USD | 6,415,000USD |
| Property Plant Equipment Net | 80,118,000USD | 92,437,000USD | 108,031,000USD | 133,969,000USD | 36,146,000USD | 22,938,000USD | 30,851,000USD | 26,294,000USD |
| Property Plant Equipment Gross | 136,731,000USD | 145,633,000USD | 183,388,000USD | 133,969,000USD | 36,146,000USD | 22,938,000USD | 30,851,000USD | 26,294,000USD |
| Common Stock Shares Outstanding | 8,869,742shares | 7,770,038shares | 6,400,164shares | 5,403,852shares | 4,585,143shares | 3,989,461shares | 2,832,461shares | 2,037,174shares |
| Non Current Assets Total | 88,817,000USD | 101,136,000USD | 183,190,000USD | 154,020,000USD | 51,231,000USD | 74,163,000USD | 32,251,000USD | 27,807,000USD |
| Non Current Liabilities Total | 74,652,999USD | 84,804,000USD | 304,797,000USD | 252,405,000USD | 141,094,000USD | 121,775,000USD | 134,771,000USD | 126,476,000USD |
| Non Current Liabilities Other | 2,077,000USD | 1,838,000USD | 1,628,000USD | 201,814,000USD | 116,451,000USD | 97,136,000USD | 110,123,000USD | 124,260,000USD |
| Non Currrent Assets Other | 31,000USD | 31,000USD | 65,573,000USD | 10,465,000USD | 14,590,000USD | 1,400,000USD | 1,400,000USD | 113,000USD |
| Net Working Capital | 30,054,000USD | -2,548,000USD | 76,751,000USD | 109,168,000USD | 221,370,000USD | 222,362,000USD | 54,196,000USD | 50,624,000USD |
| Unclassified Non Current Assets | 8,668,000USD | 8,668,000USD | 9,586,000USD | -10,465,000USD | -14,590,000USD | -60,266,000USD | -2,800,000USD | -1,513,000USD |
| Unclassified Non Current Liabilities | 72,575,999USD | 82,966,000USD | 201,625,000USD | -93,872,000USD | -98,493,000USD | -86,575,000USD | -94,447,000USD | -126,476,000USD |
| Unclassified Equity | 1,016,601,000USD | 991,537,000USD | 933,109,000USD | 875,056,000USD | 745,737,000USD | 723,391,000USD | 438,927,000USD | 361,544,000USD |
| Current Deferred Revenue | — | — | 7,730,000USD | 4,259,000USD | 16,819,000USD | 22,602,000USD | 25,794,000USD | 20,419,000USD |
| Long Term Debt | — | — | 101,544,000USD | 50,591,000USD | 24,643,000USD | 24,639,000USD | 24,648,000USD | — |
| Short Term Investments | — | — | 0USD | 18,311,000USD | 110,704,000USD | 137,567,000USD | 29,690,000USD | 0USD |
| Inventory | — | — | 29,647,000USD | 0USD | — | 1USD | -29,690,000USD | — |
| Unclassified Current Assets | — | — | -8,674,000USD | — | — | — | — | -6,845,000USD |
| Other Liab | — | — | — | 93,872,000USD | 98,493,000USD | 86,575,000USD | 94,447,000USD | 126,476,000USD |
| Other Assets | — | — | — | 20,051,000USD | 14,590,000USD | 60,266,000USD | 1,400,000USD | 1,513,000USD |
| Short Long Term Debt | — | — | — | 456,000USD | — | 454,000USD | — | — |
| Long Term Investments | — | — | — | 0USD | 495,000USD | 49,825,000USD | 1,400,000USD | 1,400,000USD |
| Accumulated Other Comprehensive Income | — | — | — | -12,000USD | -60,000USD | -47,000USD | -27,742,000USD | -20,301,000USD |
| Net Tangible Assets | — | — | — | 10,783,000USD | 131,507,000USD | 174,750,000USD | -48,324,000USD | -48,045,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 2,216,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -12,066,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -19,913,000USD | -15,335,000USD | 8,204,000USD | -19,855,000USD | 32,682,000USD | -15,637,000USD | 88,776,000USD | -32,870,000USD |
| Depreciation | 781,000USD | 954,000USD | 1,044,000USD | 1,059,000USD | 1,076,000USD | 1,085,000USD | 1,404,000USD | 1,420,000USD |
| Stock Based Compensation | 1,766,000USD | 3,199,000USD | 2,482,000USD | 2,340,000USD | 2,819,000USD | 3,765,000USD | 5,183,000USD | 5,534,000USD |
| Other Non Cash Items | 2,255,000USD | 1,994,000USD | 2,125,000USD | 2,064,000USD | 2,045,000USD | 2,031,000USD | -155,833,000USD | 2,742,000USD |
| Change To Account Receivables | 284,000USD | 260,000USD | 105,000USD | 1,879,000USD | -693,000USD | -2,068,000USD | 9,927,000USD | -11,183,000USD |
| Change In Working Capital | -1,249,000USD | -5,522,000USD | -11,649,000USD | 1,103,000USD | -11,712,000USD | -30,126,000USD | 25,790,000USD | -16,637,000USD |
| Total Cash From Operating Activities | -16,360,000USD | -14,710,000USD | 2,206,000USD | -13,289,000USD | 26,910,000USD | -38,882,000USD | -34,680,000USD | -39,811,000USD |
| Capital Expenditures | 0USD | -29,000USD | -8,000USD | -181,000USD | -34,000USD | -90,000USD | -129,000USD | -99,000USD |
| Free Cash Flow | -16,360,000USD | -14,739,000USD | 2,198,000USD | -13,470,000USD | 26,876,000USD | -38,972,000USD | -34,809,000USD | -39,910,000USD |
| Total Cash From Financing Activities | 428,000USD | 12,657,000USD | 61,000USD | 0USD | 1,180,000USD | 1,737,000USD | -110,871,000USD | 0USD |
| Issuance Of Capital Stock | 400,000USD | 12,171,000USD | 0USD | 0USD | 996,000USD | 1,737,000USD | 3,384,000USD | 0USD |
| Change In Cash | -15,932,000USD | -1,872,000USD | 2,259,000USD | -13,470,000USD | 28,056,000USD | -37,236,000USD | -4,408,000USD | -38,509,000USD |
| Begin Period Cash Flow | 54,434,000USD | 56,306,000USD | 54,047,000USD | 67,517,000USD | 39,461,000USD | 76,697,000USD | 81,105,000USD | 119,614,000USD |
| End Period Cash Flow | 38,502,000USD | 54,434,000USD | 56,306,000USD | 54,047,000USD | 67,517,000USD | 39,461,000USD | 76,697,000USD | 81,105,000USD |
| Other Cashflows From Financing Activities | 428,000USD | 12,657,000USD | 61,000USD | — | 184,000USD | -127,905,000USD | 13,650,000USD | 1,302,000USD |
| Change To Inventory | — | 0USD | 0USD | 0USD | 0USD | 0USD | -10,445,000USD | -11,024,000USD |
| Total Cashflows From Investing Activities | — | 181,000USD | -8,000USD | -181,000USD | -34,000USD | -90,000USD | 141,143,000USD | 1,302,000USD |
| Net Borrowings | — | 0USD | — | — | — | 0USD | -127,905,000USD | — |
| Other Cashflows From Investing Activities | — | 210,000USD | — | — | — | — | 127,756,000USD | 1,401,000USD |
| Unclassified Financing Cash Flow | — | -12,171,000USD | — | — | — | 127,905,000USD | — | -1,302,000USD |
| Investments | — | — | -8,000USD | -181,000USD | -34,000USD | -90,000USD | 141,143,000USD | 1,302,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | -127,627,000USD | -1,302,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 5,696,000USD | 136,000USD | -113,724,000USD | -250,157,000USD | -65,578,000USD | -89,127,000USD | -70,279,000USD | -98,942,000USD |
| Depreciation | 4,133,000USD | 5,468,000USD | 6,243,000USD | 6,629,000USD | 5,947,000USD | 6,578,000USD | 7,603,000USD | 7,862,000USD |
| Stock Based Compensation | 10,840,000USD | 20,971,000USD | 34,101,000USD | 25,482,000USD | 20,222,000USD | 8,824,000USD | 8,344,000USD | 16,641,000USD |
| Other Non Cash Items | 8,228,000USD | -109,675,000USD | 15,003,000USD | 7,621,000USD | 4,567,000USD | 3,312,000USD | 2,336,000USD | -214,000USD |
| Change To Account Receivables | 1,551,000USD | -2,068,000USD | -8,674,000USD | 1,250,000USD | 9,387,000USD | -7,602,000USD | -1,785,000USD | -1,785,000USD |
| Change To Inventory | 0USD | -33,795,000USD | -29,647,000USD | 0USD | 27,138,000USD | -2,871,000USD | -3,862,000USD | — |
| Change In Working Capital | -27,780,000USD | -65,509,000USD | -58,977,000USD | -18,391,000USD | 41,530,000USD | -23,197,000USD | -24,627,000USD | 11,799,000USD |
| Total Cash From Operating Activities | 1,117,000USD | -148,609,000USD | -117,354,000USD | -228,816,000USD | 6,688,000USD | -93,610,000USD | -76,520,000USD | -62,854,000USD |
| Capital Expenditures | -252,000USD | -380,000USD | -7,975,000USD | -9,821,000USD | -9,566,000USD | -591,000USD | -1,002,000USD | -1,937,000USD |
| Free Cash Flow | 865,000USD | -148,989,000USD | -125,329,000USD | -238,637,000USD | -2,878,000USD | -94,201,000USD | -77,522,000USD | -64,791,000USD |
| Investments | 0USD | 142,293,000USD | 17,385,000USD | 92,249,000USD | 73,654,000USD | -158,300,000USD | -29,516,000USD | 114,255,000USD |
| Total Cashflows From Investing Activities | -42,000USD | 142,293,000USD | 10,582,000USD | 82,428,000USD | 64,088,000USD | -158,891,000USD | -30,518,000USD | 112,318,000USD |
| Net Borrowings | 0USD | -127,905,000USD | 50,518,000USD | 25,699,000USD | -948,000USD | -948,000USD | 24,575,000USD | 25,000,000USD |
| Total Cash From Financing Activities | 13,898,000USD | -90,372,000USD | 71,705,000USD | 129,602,000USD | 1,178,000USD | 303,424,000USD | 86,231,000USD | 268,000USD |
| Issuance Of Capital Stock | 13,167,000USD | 23,530,000USD | 12,898,000USD | 101,168,000USD | -271,000USD | 268,641,000USD | 61,215,000USD | 61,000USD |
| Change In Cash | 14,973,000USD | -96,689,000USD | -35,065,000USD | -16,787,000USD | 71,953,000USD | 50,923,000USD | -20,807,000USD | 49,732,000USD |
| Begin Period Cash Flow | 39,461,000USD | 136,150,000USD | 171,215,000USD | 188,002,000USD | 116,049,000USD | 65,126,000USD | 85,933,000USD | 36,201,000USD |
| End Period Cash Flow | 54,434,000USD | 39,461,000USD | 136,150,000USD | 171,215,000USD | 188,002,000USD | 116,049,000USD | 65,126,000USD | 85,933,000USD |
| Other Cashflows From Investing Activities | 210,000USD | -13,516,000USD | — | 92,249,000USD | 73,654,000USD | -19,900,000USD | -29,516,000USD | 114,255,000USD |
| Other Cashflows From Financing Activities | 13,898,000USD | 14,003,000USD | 3,028,000USD | 2,735,000USD | 2,126,000USD | 14,883,000USD | 16,000USD | 404,000USD |
| Unclassified Financing Cash Flow | -13,167,000USD | — | 5,261,000USD | 1,712,000USD | -2,126,000USD | 30,858,000USD | — | -24,939,000USD |
| Unclassified Investing Cash Flow | — | 13,896,000USD | 1,172,000USD | -92,249,000USD | -73,654,000USD | 19,900,000USD | 29,516,000USD | -114,255,000USD |
| Change To Liabilities | — | — | — | 2,203,000USD | 5,005,000USD | 2,612,000USD | -4,368,000USD | 379,000USD |
| Sale Purchase Of Stock | — | — | — | 99,456,000USD | 2,126,000USD | 258,631,000USD | 60,968,000USD | -197,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -16,786,000USD | 71,954,000USD | 50,923,000USD | -20,807,000USD | 49,732,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2021Yearly · 2021-12-31 | Product | License | 131,343,000 | USD | 0000950170-24-025464 |
| FY 2021Yearly · 2021-12-31 | Product | Services | 2,068,000 | USD | 0000950170-24-025464 |
| Q2 2018Quarterly · 2018-06-30 | Product | Grant | 341,000 | USD | 0001564590-18-018757 |
| Q2 2018Quarterly · 2018-06-30 | Product | License And Service | 4,271,000 | USD | 0001564590-18-018757 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.